Market Research Logo

Active Biotech AB (ACTI) - Financial and Strategic SWOT Analysis Review

Active Biotech AB (ACTI) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Active Biotech AB (Active Biotech) is a biotechnology company that undertakes the development and commercialization of pharmaceuticals in the field of inflammatory/neurodegenerative diseases and cancer. The company has five projects in clinical development of which three have been licensed out. Its key products in development include Laquinimod (neurodegenerative diseases); Anyara (cancer); Tasquinimod (cancer); Paquinimod (Systemic Sclerosis); and SILC (autoimmune diseases). Its operations are principally focused on the laquinimod projects, which are focused on the treatment of neurodegenerative/inflammatory diseases. Active Biotech has licensing agreements with Teva Pharmaceutical Industries, NeoTX, Ipsen, Teva Neuroscience and MediGene AG. Active Biotech is headquartered in Lund, Sweden.

Active Biotech AB Key Recent Developments

Apr 27,2017: Active Biotech: Interim Report January - March 2017
Feb 16,2017: Active Biotech Year-end report January - December 2016
Aug 11,2016: Active Biotech Interim report January - June 2016
Apr 28,2016: Active Biotech Interim report January - March 2016
Feb 18,2016: Active Biotech Year-end report January - December 2015

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Active Biotech AB - Key Facts
Active Biotech AB - Key Employees
Active Biotech AB - Key Employee Biographies
Active Biotech AB - Major Products and Services
Active Biotech AB - Pharmaceutical Pipeline Products Data
Active Biotech AB, Pipeline Products by Therapy Area
Active Biotech AB, Pipeline Products by Development Phase
Active Biotech AB - History
Active Biotech AB - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Active Biotech AB - Business Description
Active Biotech AB - SWOT Analysis
SWOT Analysis - Overview
Active Biotech AB - Strengths
Active Biotech AB - Weaknesses
Active Biotech AB - Opportunities
Active Biotech AB - Threats
Active Biotech AB - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Active Biotech AB, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 27, 2017: Active Biotech: Interim Report January - March 2017
Feb 16, 2017: Active Biotech Year-end report January - December 2016
Aug 11, 2016: Active Biotech Interim report January - June 2016
Apr 28, 2016: Active Biotech Interim report January - March 2016
Feb 18, 2016: Active Biotech Year-end report January - December 2015
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tabless
Active Biotech AB, Key Facts
Active Biotech AB, Key Employees
Active Biotech AB, Key Employee Biographies
Active Biotech AB, Major Products and Services
Active Biotech AB, Number of Pipeline Products by Therapy Area
Active Biotech AB, Number of Pipeline Products by Development Stage
Active Biotech AB, History
Active Biotech AB, Subsidiaries
Active Biotech AB, Key Competitors
Active Biotech AB, Ratios based on current share price
Active Biotech AB, Annual Ratios
Active Biotech AB, Annual Ratios (Cont...1)
Active Biotech AB, Interim Ratios
Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Active Biotech AB, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Active Biotech AB, Pipeline Products by Therapy Area
Active Biotech AB, Pipeline Products by Development Phase
Active Biotech AB, Performance Chart (2012 - 2016)
Active Biotech AB, Ratio Charts
Active Biotech AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Active Biotech AB, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report